PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

August 23, 2017

Study Completion Date

October 11, 2017

Conditions
Bleeding
Interventions
DRUG

PeproStat

solution for local application

DRUG

Saline

solution for local application

Trial Locations (5)

10000

"University Clinical Hospital Centre Sestre Milosrdnice, Vinogradska cesta 29", Zagreb

11000

Clinical centre of Serbia, Clinic for vascular and endovascular surgery, Koste Todorovica Street 8, Belgrade

71000

University Clinical Hospital, Bolnicka 25, Sarajevo

80-952

Klinika Neurochirurgii Gdanskie Centrum Kliniczne, ul. Dębinki 7, Gdansk

CB2 0QQ

Addenbrookes Hospital, Cambridge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Haemostatix Ltd

INDUSTRY